0001250853-19-000020.txt : 20190104
0001250853-19-000020.hdr.sgml : 20190104
20190104204146
ACCESSION NUMBER: 0001250853-19-000020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190102
FILED AS OF DATE: 20190104
DATE AS OF CHANGE: 20190104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chin Richard
CENTRAL INDEX KEY: 0001337252
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36225
FILM NUMBER: 19512009
MAIL ADDRESS:
STREET 1: C/O OXIGENE, INC.
STREET 2: 230 THIRD AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kindred Biosciences, Inc.
CENTRAL INDEX KEY: 0001561743
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461160142
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650-701-7901
MAIL ADDRESS:
STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200
CITY: BURLINGAME
STATE: CA
ZIP: 94010
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-01-02
0
0001561743
Kindred Biosciences, Inc.
KIN
0001337252
Chin Richard
C/O KINDRED BIOSCIENCES, INC.
1555 BAYSHORE HIGHWAY, SUITE 200
BURLINGAME
CA
94010
1
1
1
0
Chief Executive Officer
Common Stock
2019-01-02
4
S
0
40000
10.5679
D
1906071
D
The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 11, 2017.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.41 to $10.91, inclusive.
/s/ Marc L. Brown, Attorney-in-Fact
2019-01-04